160 related articles for article (PubMed ID: 2497028)
1. Abnormal tau species are produced during Alzheimer's disease neurodegenerating process.
Flament S; Delacourte A
FEBS Lett; 1989 Apr; 247(2):213-6. PubMed ID: 2497028
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two pathological tau protein, variants in Alzheimer brain cortices.
Flament S; Delacourte A; Hémon B; Défossez A
J Neurol Sci; 1989 Sep; 92(2-3):133-41. PubMed ID: 2509637
[TBL] [Abstract][Full Text] [Related]
3. Pathological proteins Tau 64 and 69 are specifically expressed in the somatodendritic domain of the degenerating cortical neurons during Alzheimer's disease. Demonstration with a panel of antibodies against Tau proteins.
Delacourte A; Flament S; Dibe EM; Hublau P; Sablonnière B; Hémon B; Shérrer V; Défossez A
Acta Neuropathol; 1990; 80(2):111-7. PubMed ID: 2117840
[TBL] [Abstract][Full Text] [Related]
4. Protein TAU variants present in paired helical filaments (PHFs) of Alzheimer brains.
Gache Y; Ricolfi F; Guilleminot J; Theiss G; Nunez J
FEBS Lett; 1990 Oct; 272(1-2):65-8. PubMed ID: 2121538
[TBL] [Abstract][Full Text] [Related]
5. [Direct demonstration of abnormal phosphorylation of Tau microtubular proteins in Alzheimer's disease].
Flament S; Delacourte A; Hemon B; Defossez A
C R Acad Sci III; 1989; 308(3):77-82. PubMed ID: 2493316
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of Tau proteins: a major event during the process of neurofibrillary degeneration. A comparative study between Alzheimer's disease and Down's syndrome.
Flament S; Delacourte A; Mann DM
Brain Res; 1990 May; 516(1):15-9. PubMed ID: 2142011
[TBL] [Abstract][Full Text] [Related]
7. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
[TBL] [Abstract][Full Text] [Related]
8. Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type.
Flament S; Delacourte A; Verny M; Hauw JJ; Javoy-Agid F
Acta Neuropathol; 1991; 81(6):591-6. PubMed ID: 1831952
[TBL] [Abstract][Full Text] [Related]
9. Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.
Brion JP; Hanger DP; Bruce MT; Couck AM; Flament-Durand J; Anderton BH
Biochem J; 1991 Jan; 273(Pt 1)(Pt 1):127-33. PubMed ID: 1899184
[TBL] [Abstract][Full Text] [Related]
10. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
Papasozomenos SC
Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of neurofibrillary degeneration in Alzheimer's disease.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Singh TJ; Grundke-Iqbal I
Mol Neurobiol; 1994; 9(1-3):119-23. PubMed ID: 7888088
[TBL] [Abstract][Full Text] [Related]
12. [Alzheimer's disease: study of the distribution of tau proteins constituting helical filament pairs in human central nervous tissue].
Parent M; Delacourte A; Défossez A; Hémon B; Han KK; Petit H
C R Acad Sci III; 1988; 306(13):391-7. PubMed ID: 3136867
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.
Bancher C; Brunner C; Lassmann H; Budka H; Jellinger K; Wiche G; Seitelberger F; Grundke-Iqbal I; Iqbal K; Wisniewski HM
Brain Res; 1989 Jan; 477(1-2):90-9. PubMed ID: 2495152
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: Tau proteins, the promoting factors of microtubule assembly, are major components of paired helical filaments.
Delacourte A; Defossez A
J Neurol Sci; 1986 Dec; 76(2-3):173-86. PubMed ID: 3098926
[TBL] [Abstract][Full Text] [Related]
15. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease.
Ihara Y; Nukina N; Miura R; Ogawara M
J Biochem; 1986 Jun; 99(6):1807-10. PubMed ID: 2427509
[TBL] [Abstract][Full Text] [Related]
17. Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration.
Flament S; Delacourte A; Delaère P; Duyckaerts C; Hauw JJ
Acta Neuropathol; 1990; 80(2):212-5. PubMed ID: 2117842
[TBL] [Abstract][Full Text] [Related]
18. Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.
Gong CX; Grundke-Iqbal I; Iqbal K
Neuroscience; 1994 Aug; 61(4):765-72. PubMed ID: 7838376
[TBL] [Abstract][Full Text] [Related]
19. Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.
Wang JZ; Xia YY; Grundke-Iqbal I; Iqbal K
J Alzheimers Dis; 2013; 33 Suppl 1():S123-39. PubMed ID: 22710920
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary degeneration and microtubule associated protein tau.
Yen SH; Liu WK
Chin J Physiol; 1992; 35(4):357-66. PubMed ID: 1308732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
